Citadel Advisors
NBP

Citadel Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Citadel Advisors’s Portfolio NBP Stock Details NBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-39,500
Closed -$157K – 13568
2025
Q4 		$157K Sell
39,500
-2,800
-7% -$12.4K ﹤0.01% 11264
2025
Q3 		$160K Buy
+42,300
New +$144K ﹤0.01% 11487
2025
Q2 		– Sell
-13,300
Closed -$11K – 13714
2025
Q1 		$11K Sell
13,300
-1,200
-8% -$1.14K ﹤0.01% 13519
2024
Q4 		$12.3K Buy
14,500
+8,700
+150% +$9.68K ﹤0.01% 13504
2024
Q3 		$7.19K Buy
5,800
+3,900
+205% +$4.88K ﹤0.01% 13378
2024
Q2 		$3.17K Sell
1,900
-1,600
-46% -$2.86K ﹤0.01% 13617
2024
Q1 		$6.51K Buy
3,500
+100
+3% +$184 ﹤0.01% 13666
2023
Q4 		$6.46K Sell
3,400
-9,300
-73% -$13.9K ﹤0.01% 13349
2023
Q3 		$16.8K Buy
12,700
+3,500
+38% +$7.69K ﹤0.01% 12763
2023
Q2 		$27.5K Buy
9,200
+200
+2% +$642 ﹤0.01% 12444
2023
Q1 		$31.1K Buy
9,000
+5,000
+125% +$24.2K ﹤0.01% 12703
2022
Q4 		$16.7K Buy
+4,000
New +$15.1K ﹤0.01% 13273
2022
Q2 		– Sell
-10,900
Closed -$177K – 13444
2022
Q1 		$177K Sell
10,900
-7,600
-41% -$195K ﹤0.01% 11667
2021
Q4 		$877K Sell
18,500
-5,200
-22% -$312K ﹤0.01% 8276
2021
Q3 		$1.72M Sell
23,700
-400
-2% -$28.9K ﹤0.01% 6751
2021
Q2 		$2.02M Buy
+24,100
New +$1.59M ﹤0.01% 6593

Other funds holding NBP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
ACM
AIHC Capital Management Central $120M AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's NBP Position: Q1 2026 in Review

Citadel Advisors opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2026: 166,616 shares worth $410K. The stake represents ﹤0.01% of the portfolio and ranks #9765 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in NBP as recently as Q4 2024.

Citadel Advisors first reported a position in NBP in Q4 2020 and has held it in 15 quarters since. The position peaked at $3.63M in Q4 2020. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • Citadel Advisors held 166,616 shares of NovaBridge Biosciences American Depositary Shares worth $410K as of Q1 2026.
  • NovaBridge Biosciences American Depositary Shares was a new Citadel Advisors position in Q1 2026.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9765 holding.
  • Citadel Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 15 quarters since.
  • Citadel Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $3.63M in Q4 2020.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.